Search results

Found 5,000 pages
AUTHOR: Kevin Grogan

Your search yielded no results

  • Check if your spelling is correct.
  • Remove quotes around phrases to search for each word individually. bike shed will often show more results than "bike shed".
  • Consider loosening your query with OR. bike OR shed will often show more results than bike shed.

CHMP positive on GSK diabetes drug Eperzan

Advisors to the European Medicines Agency have recommended approval of GlaxoSmithKline's once-weekly diabetes drug Eperzan. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/chmp_positive_on_gsk_diabetes_drug_eperzan_1001416

Eisai buys AkaRx for $255 million

Eisai is acquiring the US firm AkaRx in a deal which will give the Japanese drugmaker access to a mid-stage thrombocytopaenia drug. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/eisai_buys_akarx_for_$255_million_984073

Moderna raises massive $450 million

Moderna Therapeutics has caused a stir by raising a whopping $450 million, reportedly the largest-ever private financing round for any biotech. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/moderna_raises_massive_$450_million_970819

Mayne Pharma buys Metrics

Australia's Mayne Pharma is to buy Metrics, a privately-owned US-based provider of contract development services to the pharma industry in a deal worth up to $120 million. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/mayne_pharma_buys_metrics_976489

Takeda sets up subsidiary in Israel

As part of its strategy of expanding in growth markets, Takeda is establishing a subsidiary in Israel. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/takeda_sets_up_subsidiary_in_israel_1006206

Astellas/Daiichi Sankyo high throughput screening pact

Astellas Pharma and Daiichi Sankyo have unveiled plans for a compound-library sharing partnership, the largest such pact to be formed in Japan. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/astellasdaiichi_sankyo_high_throughput_screening_pact_1001693

AZ expands cancer pipeline with Probiodrug pact

AstraZeneca has acquired a cyclin-dependent kinase 9 inhibitor programme, targeting cancer and inflammatory diseases, from Germany's Probiodrug. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/az_expands_cancer_pipeline_with_probiodrug_pact_1001308

CHMP turns down Vanda schizophrenia drug

Vanda Pharmaceuticals has been stunned by a recommendation from European regulators that the US firm's schizophrenia drug Fanaptum should not get the green light. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/chmp_turns_down_vanda_schizophrenia_drug_976028

Mundipharma and Esteve sign major pain pact

Mundipharma and associate Purdue Pharmaceuticals have linked up with Spain’s Esteve to develop “important next-generation products” for the management of pain. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/mundipharma_and_esteve_sign_major_pain_pact_970859

UCB launches biotech facility in Belgium

UCB has opened the doors to its 65 million euro biotechnology plant in Belgium. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/ucb_launches_biotech_facility_in_belgium_976631

Latest jobs

View all

What job are you looking for?

This field is required.

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download